← Back to home

CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY

Clinical trials for CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear

Sign up with your email to follow new studies for CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Eye drop trial aims to halt diabetic vision damage

Disease control Completed

This study tested whether a new eye drop called INV-102 could help control diabetic retinopathy, a common cause of vision loss. It involved 19 adults with diabetes who had swelling in the back of the eye. Researchers gave participants the eye drops for 8-12 weeks to see if it red…

Matched conditions: CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY

Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY

Get alerted when new CENTER-INVOLVED DIABETIC MACULAR EDEMA ASSOCIATED WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear

Eye drop trial aims to halt diabetic vision damage